HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 214 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,543,471 | +178.2% | 40,405 | +162.6% | 0.19% | +167.1% |
| Q2 2023 | $554,901 | -79.0% | 15,384 | -77.8% | 0.07% | -76.7% |
| Q1 2023 | $2,646,300 | +24.1% | 69,293 | +84.9% | 0.30% | +23.5% |
| Q4 2022 | $2,132,953 | +341.6% | 37,486 | +209.5% | 0.24% | +367.3% |
| Q1 2022 | $483,000 | -86.9% | 12,113 | -86.6% | 0.05% | -81.6% |
| Q3 2021 | $3,690,000 | +344.6% | 90,705 | +355.6% | 0.28% | +293.1% |
| Q1 2021 | $830,000 | -22.0% | 19,907 | -50.8% | 0.07% | +5.9% |
| Q3 2020 | $1,064,000 | +20.0% | 40,490 | +22.4% | 0.07% | -16.0% |
| Q2 2020 | $887,000 | +124.0% | 33,078 | +48.1% | 0.08% | +237.5% |
| Q4 2019 | $396,000 | – | 22,335 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |